PubGene

What PubGene does

PubGene is a Norwegian bioinformatics company founded in 2001 and headquartered in Oslo, with a US parent (PubGene Inc.) and wholly-owned subsidiaries including Coremine Vitae AS, Vitae Evidence AS, and Sencel AS. The company has built the COREMINE Platform, a proprietary stack that applies advanced statistical text mining and specialized natural language processing (NLP) over large biomedical repositories (MEDLINE, PubMed, DrugBank, ClinicalTrials.gov), representing knowledge as intuitive graphical networks rather than flat search results.

On top of the COREMINE Platform, PubGene operates a portfolio of products: Coremine Medical, a free internet service for medical professionals and biomedical researchers; Coremine Oncology, which analyses cancer-specific mutational profiles from next-generation sequencing biopsies to identify druggable mutations and clinical-trial matches; Coremine Vitae, a CE-marked Class I Medical Device that delivers personalized biomarker-driven treatment intelligence to hospitals and patients via API licensing and direct B2C reports; and Vitae Evidence, a SaaS product spun out for evaluating evidence supporting personalized treatment options. Manufacturing and quality processes for Coremine Vitae follow EN ISO 13485:2016, EN ISO 14971:2012, EN 62304, and EN 62366-1.

The business model combines a freemium knowledge community (Coremine Medical), a regulated enterprise-clinical SaaS/API product (Coremine Vitae via B2B API licensing and annual subscription reports, including a non-personalized Vitae Mini tier), and R&D co-development revenues via European consortia such as the Eurostars Pathobody, AntiSeptic, and GlioPhos projects. Customer concentration is heavily Norwegian-academic-hospital-centric (Haukeland University Hospital, Oslo University Hospital, Moloklinikken, the Norwegian Cancer Genomics Consortium, Oslo Cancer Cluster), with reach extending internationally via the free Coremine Medical product to 10,000+ users across 120+ countries as of March 2024.

Name

PubGene

Legal name

PubGene AS

Website

https://pubgene.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

PubGene is a Norwegian bioinformatics company that builds proprietary NLP-driven clinical decision support products, including the free Coremine Medical search tool and CE-marked Coremine Vitae personalized medicine platform, for hospitals, clinicians, sequencing providers, and patients.

Ownership category

akta.pro rank

Product category

Biomedical Informatics Software

NAICS

Software Publishers (513210), Web Search Portals, Libraries, Archives, and Other Information Services (519)

SIC

Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro industry

PRIMARYHLACANAM

DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLACANAF

SaMD – Digital Biomarkers & Algorithmic Endpoints

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

SECONDARYHLACANAH

Therapeutic Companion Apps (Drug-Device-Digital Combination)

Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

• Biomedical text mining
• Clinical decision support
• Precision medicine software
• Biomedical NLP platform
• Personalized medicine reports

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. B2B API Licensing: Primary business line offering Coremine Vitae to healthcare providers globally through licensing the Application Programming Interface (API) for data exchange with health information systems.
2. Coremine Vitae Biomedical Intelligence Reports: B2C offering of personalized and non-personalized (Coremine Vitae Mini) biomedical intelligence reports to patients, their treating clinicians, and other stakeholders in selected countries. Personalized reports are based on patient biomarkers.
3. Coremine Medical Free Service: Free internet service for medical professionals providing access to medical information search, with potential for premium features or data services in the future.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

PubGene develops and sells the COREMINE Platform, a proprietary text mining and NLP-based system for mining large biomedical repositories and presenting knowledge through graphical networks. Built on this platform are specialized applications including Coremine Medical (free biomedical search service), Coremine Oncology (cancer mutational profiling analysis), and Coremine Vitae (CE-marked Class I Medical Device Software offering personalized and non-personalized biomedical intelligence reports to healthcare providers and patients).

Product overview

PubGene offers a platform-plus-modules architecture centered on the COREMINE Platform, which provides proprietary text mining and NLP capabilities. Built on this platform are specialized products: Coremine Medical (free information search service for health professionals), Coremine Oncology (cancer mutational profile analysis), and the spin-off products Coremine Vitae (personalized medicine platform for patients and clinicians) and Vitae Evidence (SaaS for evidence evaluation). The platform integrates big biomedical data from sources like MEDLINE, PubMed, DrugBank, and ClinicalTrials.

Differentiator

Problem solved

Functional benefit

Brands

• COREMINE Medical: The first domain-specific information community built on top of the COREMINE Platform. A free Internet service for searching, updating, and sharing medical information targeted at medical health professionals and biomedical researchers.
• COREMINE Oncology
• Coremine Vitae
• Vitae Evidence

Products and services

• COREMINE Platform PubGene's proprietary technology platform that mines large biomedical repositories using advanced statistical text mining algorithms and specialized Natural Language Processing (NLP), presenting knowledge through intuitive graphical networks providing 360-degree views of relevant information. The generic platform can be used to develop any domain-specific search engine.
• Coremine Medical First domain-specific information community built on the COREMINE Platform. Free internet service for searching, updating, and sharing medical information, targeted at medical health professionals and biomedical researchers needing to navigate complex information networks and qualify associations across MEDLINE, PubMed, DrugBank, and ClinicalTrials.
• Coremine Oncology Application that enables analysis of complex cancer-specific mutational profiles extracted from patient biopsies using next generation sequencing. Guides oncologists through mutational analysis, identifies key drivable and druggable mutations, and helps select optimal treatment regimens or clinical trials.
• Coremine Vitae CE-marked Class I Medical Device Software platform for personalised medicine that enables healthcare institutions to find the best possible treatments based on each patient's individual medical profile, including molecular and genetic biomarkers. Offered B2B via API licensing to healthcare providers globally and B2C via personalized and non-personalized biomedical intelligence reports to patients and clinicians in selected countries.
• Vitae Evidence SaaS solution for efficiently finding and evaluating evidence for personalized treatment options tailored to each patient's molecular profile and preferences. CE-marked Medical Device Software platform developed by the PubGene spin-off Vitae Evidence AS.

Quantifiable outcome

• Over 10,000 users from 120+ countries

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

13 partnerships are on record, tiered core and minor.

• Da Vinci laboratory solution B.V.coreStrategic or Co-development Partner · 1 July 2022Eurostars AntiSeptic project partner developing technology platform for rapid identification of causative bacterial species in bloodstream infections by identifying their mechanisms of resistance.
• Evosep ApscoreStrategic or Co-development Partner · 1 July 2022Eurostars AntiSeptic project partner contributing automated sample preparation and measurement technology for mass-spectrometry based bloodstream infection identification.
• AbSano B.V.coreStrategic or Co-development Partner · 1 April 2021Eurostars project partner for Pathobody project aimed at developing a platform for recovery of pathogen-specific antibody molecules from exposed patients for generating high value monoclonal antibody leads using NGS, phage display, proteomics and bioinformatics.
• Erasmus MCcoreStrategic or Co-development Partner · 1 April 2021Multiple Eurostars project partner (Pathobody, AntiSeptic, GlioPhos) collaborating on pathogen antibody recovery, bloodstream infection identification, and glioblastoma phosphoproteomic profiling.
• GenXPro GmbHcoreStrategic or Co-development Partner · 1 April 2021Eurostars project partner for Pathobody project combining NGS, phage display, proteomics and bioinformatics for pathogen-specific antibody molecule recovery.
• Norway Health TechminorStrategic or Co-development Partner · 1 May 2020Norway's largest health cluster with 250 members facilitating contact between health service needs and industry players. Partner in pre-study on COREMINE Medical decision support for Covid-19.
• Moloklinikken AScoreStrategic or Co-development Partner · 1 August 2019Innovation contract to define, develop and streamline Coremine Vitae biomedical intelligence report as a combined personalised medicine information tool and service. Innovation Norway funded project.
• Haukeland University HospitalcoreStrategic or Co-development Partner · 1 June 2019Collaboration with Section for Research and Innovation to clinically validate Coremine Vitae, provide feedback on product development, and facilitate CMV patient trials.
• Nansen Neuroscience NetworkminorStrategic or Co-development Partner · 1 May 2019Non-profit life science organization accelerating innovation from Nordic neuroscience research. PubGene is exploring neuro disease applications as scientific discoveries and clinical validation mature.
• PepscopecoreStrategic or Co-development Partner · 1 January 2019Eurostars GlioPhos project partner providing mass spectrometry platform to determine phosphoproteomic profiles from glioblastoma patients combined with Coremine bioinformatic analysis.
• Oslo University HospitalcoreStrategic or Co-development Partner · 1 January 2015Partner in Norwegian Cancer Genomics Consortium's groundbreaking tumor sequencing program through which Coremine Oncology is being developed.
• Norwegian Cancer Genomics ConsortiumcoreStrategic or Co-development Partner · 1 January 2015Collaborative partner in groundbreaking Norwegian tumor sequencing program essential for Coremine Oncology product development and cancer mutational profile analysis.
• Oslo Cancer ClustercoreStrategic or Co-development Partner · 1 January 2015Collaborative partner in cancer research ecosystem supporting development of oncology solutions and Coremine product family.

Scale indicators3 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Sophia Genetics: Sophia Genetics operates a SaaS platform (SOPHiA DDM) that uses AI and text/data mining to analyze genomic and biomedical data for hospitals and clinicians, closely matching PubGene's COREMINE Platform model in clinical genomics decision support.
• BC Platforms: BC Platforms builds bioinformatics and genomic data management tools for hospitals and research institutions, with a similar European footprint and precision medicine orientation to PubGene.
• Molecular Health: Molecular Health provides clinical decision support for precision oncology and personalized treatment selection using biomedical data mining — directly analogous to Coremine Vitae and Coremine Oncology's clinical interpretation use case.
• 2bPrecise: 2bPrecise delivers precision medicine analytics that translate genomic and molecular data into clinical decision support at the point of care, closely mirroring PubGene's Coremine Vitae delivery model to hospitals.
• Congenica: Congenica offers a clinical genomics interpretation platform for rare disease and oncology, overlapping with PubGene's biomarker-driven treatment decision support for hospitals.

Emerging players

• Owkin: Owkin applies AI to multimodal biomedical and clinical data for research and pharma, overlapping with PubGene's text-mining and biomarker interpretation capabilities but with a different buyer base (mostly pharma).

Broad incumbents

• DNAnexus: DNAnexus provides a genomics data management and analysis cloud platform used by hospitals and sequencing providers — adjacent infrastructure for the same biomedical data pipeline PubGene serves.
• Tempus Labs: Tempus is a broad precision medicine incumbent combining sequencing, AI-based clinical decision support, and structured data products, with Coremine Oncology directly competing in its oncology clinical interpretation offering.
• Seven Bridges (Velsera): Seven Bridges / Velsera operates a bioinformatics platform for genomic and biomedical data analysis used by research consortia and hospitals, comparable in function to the COREMINE Platform but at larger scale.
• Flatiron Health: Flatiron Health (acquired by Roche) provides oncology-specific EHR data, real-world evidence, and clinical decision tools to hospitals and life sciences — adjacent to PubGene's precision oncology interpretation stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@pubgene
• Facebookfacebook.com/PubGene
• LinkedInlinkedin.com/company/pubgene-as
• Instagraminstagram.com/pubgeneas

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PubGene